Skip to main content

Table 1 Demographic and Clinical Characteristics of 559 Participants with MDR-TB Treated at Hinduja Hospital, by Prior MDR-TB Treatment

From: Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic

  Prior MDR-TB Treatment, N = 267 No Prior MDR-TB Treatment, N = 289 All Participants, N = 559 Χ2 Test
  #/# with Complete Dataa (%) #/# with Complete Dataa (%) #/# with Complete Dataa (%) p-value
Female 163 / 267 (61.0) 184 / 289 (63.7) 349 / 559 (62.4) 0.583
Diagnosed in Private Sector 227 / 254 (89.4) 215 / 269 (79.9) 444 / 525 (84.6) 0.004
Current Student 66 / 267 (24.7) 67 / 289 (23.2) 133 / 559 (23.8) 0.746
Health Care Worker 13 / 267 (4.9) 19 / 289 (6.6) 33 / 559 (5.9) 0.889
Left Work or School Due to TB 107 / 267 (40.1) 140 / 289 (48.4) 247 / 559 (44.2) 0.026
Current or Former Smoker 11 / 214 (5.1) 28 / 268 (10.4) 39 / 485 (8.0) 0.051
Household Contact with MDR-TB 35 / 224 (15.6) 55 / 269 (20.4) 90 / 496 (18.1) 0.207
Pulmonary TB Only 192 / 267 (71.9) 221 / 289 (76.5) 415 / 559 (74.2) 0.168
Cavitary Lesions on X-ray 118 / 227 (52.0) 146 / 241 (60.6) 266 / 470 (56.6) 0.075
HIV Positive 1 / 138 (0.7) 1 / 163 (0.6) 2 / 301 (0.7) 1.000
Diabetic 18 / 99 (18.2) 18 / 49 (36.7) 36 / 148 (24.3) 0.023
Smear Positive 163 / 267 (61.0) 207 / 289 (71.6) 372 / 559 (66.5) 0.011
Culture Positive 227 / 253 (89.7) 254 / 277 (91.7) 483 / 532 (90.8) 0.527
  1. aDue to the observational nature of this cohort study, complete records were not available for all study participants. Denominators are adjusted in each field to reflect data completion among study participants